Identification of copy number gain and overexpressed genes on chromosome arm 20q by an integrative genomic approach in cervical cancer: Potential role in progression
暂无分享,去创建一个
M. Mansukhani | A. Kaufmann | V. Murty | S. Subramaniyam | S. Nandula | A. Schneider | Hugo Arias-Pulido | Luigi Scotto | Gopeshwar Narayan | Subhadra V Nandula | Shivakumar Subramaniyam | Achim Schneider | Andreas M Kaufmann | Jason D Wright | Bhavana Pothuri | Mahesh Mansukhani | Vundavalli V Murty | B. Pothuri | L. Scotto | G. Narayan | H. Arias-Pulido | J. Wright
[1] K. Basso,et al. Gene dosage alterations revealed by cDNA microarray analysis in cervical cancer: Identification of candidate amplified and overexpressed genes , 2007, Genes, chromosomes & cancer.
[2] A. Ostör. Natural history of cervical intraepithelial neoplasia: a critical review. , 1993, International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists.
[3] J. Gray,et al. Amplification of chromosomal region 20q13 in invasive breast cancer: prognostic implications. , 1995, Clinical cancer research : an official journal of the American Association for Cancer Research.
[4] M. Schwab. Oncogene amplification in solid tumors. , 1999, Seminars in cancer biology.
[5] Elena Savelieva,et al. 20q gain associates with immortalization: 20q13.2 amplification correlates with genome instability in human papillomavirus 16 E7 transformed human uroepithelial cells , 1997, Oncogene.
[6] M. Mansukhani,et al. Genetic analysis identifies putative tumor suppressor sites at 2q35–q36.1 and 2q36.3–q37.1 involved in cervical cancer progression , 2003, Oncogene.
[7] P. Meltzer,et al. Independent amplification and frequent co-amplification of three nonsyntenic regions on the long arm of chromosome 20 in human breast cancer. , 1996, Cancer research.
[8] G. Evans,et al. Identification of a 6-cM minimal deletion at 11q23.1-23.2 and exclusion of PPP2R1B gene as a deletion target in cervical cancer. , 2000, Cancer research.
[9] Joe W. Gray,et al. Genome Amplification of Chromosome 20 in Breast Cancer , 2003, Breast Cancer Research and Treatment.
[10] E. Jordanova,et al. Gene-specific fluorescence in-situ hybridization analysis on tissue microarray to refine the region of chromosome 20q amplification in melanoma , 2007, Melanoma research.
[11] Cheng Li,et al. dChipSNP: significance curve and clustering of SNP-array-based loss-of-heterozygosity data , 2004, Bioinform..
[12] A. Östör,et al. Natural history of cervical intraepithelial neoplasia: a critical review. , 1993, International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists.
[13] P. Meltzer,et al. Hybrid selection of transcribed sequences from microdissected DNA: isolation of genes within amplified region at 20q11-q13.2 in breast cancer. , 1996, Cancer research.
[14] Karl Münger,et al. Mechanisms of genomic instability in human cancer: Insights from studies with human papillomavirus oncoproteins , 2004, International journal of cancer.
[15] R. Richart,et al. Natural history of cervical intraepithelial neoplasia , 1967 .
[16] C J L M Meijer,et al. Increased gene copy numbers at chromosome 20q are frequent in both squamous cell carcinomas and adenocarcinomas of the cervix , 2006, The Journal of pathology.
[17] Bhuvanesh Singh,et al. Comprehensive molecular cytogenetic characterization of cervical cancer cell lines , 2003, Genes, chromosomes & cancer.
[18] S. Peñuelas,et al. Differentially expressed genes between high-risk human papillomavirus types in human cervical cancer cells , 2006, International Journal of Gynecologic Cancer.
[19] L. G. Koss,et al. Cervical Cancer , 1981, Current Topics in Pathology.
[20] P. Rao,et al. Chromosomal amplifications, 3q gain and deletions of 2q33-q37 are the frequent genetic changes in cervical carcinoma , 2004, BMC Cancer.
[21] Karl Münger,et al. Human papillomavirus immortalization and transformation functions. , 2002, Virus research.
[22] C. Li,et al. Model-based analysis of oligonucleotide arrays: expression index computation and outlier detection. , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[23] E. Schröck,et al. Gain of chromosome 3q defines the transition from severe dysplasia to invasive carcinoma of the uterine cervix. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[24] S. Ishikawa,et al. Molecular karyotyping of human hepatocellular carcinoma using single-nucleotide polymorphism arrays , 2006, Oncogene.
[25] N. Carter,et al. High-resolution analysis of genomic copy number alterations in bladder cancer by microarray-based comparative genomic hybridization , 2004, Oncogene.
[26] J. Rader,et al. Profiling microdissected epithelium and stroma to model genomic signatures for cervical carcinogenesis accommodating for covariates. , 2007, Cancer research.
[27] R. Chaganti,et al. ERBB2 (HER2/neu) oncogene is frequently amplified in squamous cell carcinoma of the uterine cervix. , 1994, Cancer research.
[28] D. K. Das,et al. Risk factors related to biological behaviour of precancerous lesions of the uterine cervix. , 1990, British Journal of Cancer.
[29] C. Reznikoff,et al. Dominant genetic alterations in immortalization: Role for 20q gain , 1999, Genes, chromosomes & cancer.
[30] V. Reuter,et al. Chromosomal amplification is associated with cisplatin resistance of human male germ cell tumors. , 1998, Cancer research.
[31] N. Christensen,et al. Keratinocyte-Secreted Laminin 5 Can Function as a Transient Receptor for Human Papillomaviruses by Binding Virions and Transferring Them to Adjacent Cells , 2006, Journal of Virology.
[32] L. Koutsky,et al. Natural history and epidemiological features of genital HPV infection. , 1992, IARC scientific publications.
[33] M. Mansukhani,et al. Frequent Promoter Methylation of CDH1, DAPK, RARB, and HIC1 Genes in Carcinoma of Cervix Uteri: Its Relationship to Clinical Outcome , 2003, Molecular Cancer.
[34] Ekaterina S Jordanova,et al. Combined array-comparative genomic hybridization and single-nucleotide polymorphism-loss of heterozygosity analysis reveals complex genetic alterations in cervical cancer , 2007, BMC Genomics.
[35] K. Maclennan,et al. Genetic events during the transformation of a tamoxifen-sensitive human breast cancer cell line into a drug-resistant clone. , 2001, Cancer genetics and cytogenetics.
[36] M. Newton,et al. Long-term genome stability and minimal genotypic and phenotypic alterations in HPV16 E7-, but not E6-, immortalized human uroepithelial cells. , 1994, Genes & development.